Trial intelligence / Profile preview

JMKX003142 in Heart Failure Patients With Volume Overload

NCT06949020Phase 2Completed

Sponsor
Jemincare
Start
Jul 2025
Primary completion
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of JMKX003142 in edema secondary to heart failure, sponsored by Jemincare. Started Jul 2025; status: completed.

02

Drugs

JMKX003142
03

Conditions

edema secondary to heart failure

Beyond the preview

Go deeper on NCT06949020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06949020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call